ArticleArthroscopy, sports medicine, and rehabilitation2026
Preoperative Risk Factors for Opioid Use Predict Self-Reported Health and Function Up to 6 Months After Anterior Cruciate Ligament Reconstruction.
Article in Arthroscopy, sports medicine, and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To identify risk factors that predict the need for rescue opioid use and patient-reported outcomes following an opioid-limiting postoperative analgesia protocol after anterior cruciate ligament reconstruction. Methods: This prospective cohort study recruited 44 patients undergoing primary arthroscopic-assisted anterior cruciate ligament reconstruction. Preoperatively, patients completed questionnaires including demographics, medical history, Visual Analog Scale (VAS), Brief Resilience Scale, Six-Item State-Trait Anxiety Inventory, Patient Health Questionnaire-2, Single Assessment Numeric Evaluation score, and patient-reported outcome measures (PROMs) including Patient-Reported Outcomes Measurement Information System physical component. Postoperatively, patients received acetaminophen, meloxicam, tramadol, gabapentin, and oxycodone. Morphine milligram equivalents (MMEs) and VAS were assessed at multiple timepoints through 6 months. PROMs were completed at 3 and 6 months. Patients were analyzed as a single group and partitioned by Brief Resilience Scale and Six-Item State-Trait Anxiety Inventory scores into low-normal (1.00-4.30) and high (4.31-5.00) resilience, and low (20-37) and moderate-high (38-80) anxiety groups, respectively. Results: Prior opioid use positively predicted VAS and MME at 48 to 72 hours and MME at 6 weeks. Body mass index positively predicted MME at 2 weeks. Surgical history negatively predicted VAS at 48 to 72 hours, but positively predicted change in Single Assessment Numeric Evaluation score at 3 and 6 months and Patient-Reported Outcomes Measurement Information System physical component score at 6 months. Conclusions: Only 4.8% of patients required opioid medications more than 2 weeks postoperatively. Patients with prior opioid use exhibited greater postoperative pain and narcotic consumption. Higher body mass index linked to increased opioid use at 2 weeks, whereas individuals with prior surgical history reported less pain and improved PROMs postoperatively. Measurements of patient resilience and anxiety show little effect on postoperative pain, opioid consumption, and PROMs requiring further study. Level of Evidence: Level III, retrospective prognostic case series.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.